Cocrystal Pharma, Inc. (COCP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$32.0K2011: -$3.89M2012: -$2.55M2013: -$4.08M2014: -$5.80M2015: -$53.95M2016: -$105.82M2017: -$8.26M2018: -$62.92M2019: -$48.41M2020: -$9.59M2021: -$14.22M2022: -$38.83M2023: -$18.56M2024: -$17.88M2025: -$9.02M-$9.02M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$9.02M+49.6%
2024-$17.88M+3.7%
2023-$18.56M+52.2%
2022-$38.83M-173.0%
2021-$14.22M-48.4%
2020-$9.59M+80.2%
2019-$48.41M+23.1%
2018-$62.92M-661.6%
2017-$8.26M+92.2%
2016-$105.82M-96.1%
2015-$53.95M-830.3%
2014-$5.80M-42.1%
2013-$4.08M-59.8%
2012-$2.55M+34.3%
2011-$3.89M-12029.8%
2010-$32.0K